For example, the activation of AKT signaling promotes drug resistance such as to cisplatin and paclitaxel in osteosarcoma and ovarian cancer cells, while the inhibition of AKT signaling promotes cell sensitivity to chemotherapy drugs [16,17,18]. The gene discussed is AKT1; the disease is ovarian cancer.